Dr Reddys Laboratories (RDY) Notes Payables (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Notes Payables of $630.0 million for Q1 2026, up 41.57% year-over-year from $445.0 million in Q1 2025, and up 41.57% quarter-over-quarter from $445.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Notes Payables (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Notes Payables history runs 9 years deep, the most recent figure standing at $630.0 million for Q1 2026.
- In Q1 2026, Notes Payables rose 41.57% year-over-year to $630.0 million; the TTM figure through Mar 2026 stood at $630.0 million (up 41.57% YoY), while the FY2026 annual figure was $630.0 million, up 41.57% from the prior year.
- Notes Payables for Q1 2026 stood at $630.0 million, up from $445.0 million in the prior quarter.
- The five-year high for Notes Payables was $630.0 million in Q1 2026, with the low at $90.0 million in Q1 2023.
- The 5-year median for Notes Payables is $357.0 million (2022), against an average of $335.0 million.
- The sharpest annual moves came in 2023 and 2025: Notes Payables plunged 74.79% in 2023, then jumped 190.85% in 2025.
- Dr Reddys Laboratories' Notes Payables stood at $357.0 million in 2022, then slumped by 74.79% to $90.0 million in 2023, then surged by 70.0% to $153.0 million in 2024, then soared by 190.85% to $445.0 million in 2025, then soared by 41.57% to $630.0 million in 2026.
- Business Quant data shows RDY's Notes Payables at $630.0 million in Q1 2026, $445.0 million in Q1 2025, and $153.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 630.00 Mn |
| Mar 31, 2025 | 445.00 Mn |
| Mar 31, 2024 | 153.00 Mn |
| Mar 31, 2023 | 90.00 Mn |
| Mar 31, 2022 | 357.00 Mn |
| Mar 31, 2020 | 1.00 Mn |
| Mar 31, 2019 | 175.00 Mn |
| Mar 31, 2018 | 391.00 Mn |
| Dec 31, 2009 | 33.00 Mn |
| Sep 30, 2009 | 43.00 Mn |
| Jun 30, 2009 | 58.00 Mn |